Skip to main content
OpenTrials
Completed

NCT Number: NCT04699474

Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury

PROMPT-SCI (Protocol for Rapid Onset of Mobilization in Patients with Traumatic SCI) is a single-site single-arm proof-of-concept trial. Forty-five patients aged 18 years or older who have sustained a severe traumatic SCI (American Spinal Injury Association Impairment Scale grade A, B or C) from C0 to L1 and undergoing spinal surgery within 48 hours of the injury will be included. Participants will receive daily 30-minute sessions of in-bed leg cycling for 14 consecutive days, initiated within 48 hours after spinal surgery. The feasibility outcomes consist of the 1) absence of serious adverse events associated with cycling sessions, 2) completion of at least 1 full session within 48 hours after spinal surgery for at least 90% of participants, and 3) completion of at least 11 sessions for at least 80% of participants. Patient outcomes 6 weeks and 6 months after injury will be measured from neurofunctional assessments, quality of life questionnaires and inpatient length of stay. Feasibility and patient outcomes will be analysed with descriptive statistics. Patient outcomes will also be compared to a matched historical cohort not receiving in-bed cycling.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital du Sacre-Coeur de Montreal

Montreal, Quebec, H4J1C5, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Blunt traumatic spinal cord injury
  • Neurological level of injury from C0 to L2
  • American Spinal Injury Association impairment scale grade A, B or C
  • Spine surgery performed within 48 hours of injury

Exclusion criteria

  • Condition limiting patient's ability to engage into cycling
  • Medical condition that might interfere with patient's safety if cycling
  • Moderate or severe brain injury
  • Inability to walk independently prior to injury
  • Pre-existing neurological disorder
  • Complete spinal cord transection
  • Unwilling or unable to comply with scheduled follow-up

Treatment and study plan

Leg ergometer

Device

Leg cycling in bed using motorized ergometer

Primary outcomes

  1. Ambulation

    Time frame: 6 months

    Independent walking (with or without device)

Secondary outcomes

  1. Neurological recovery

    Time frame: 6 months

    International Standards for Neurological Classification of Spinal Cord Injury

  2. Function

    Time frame: 6 months

    Spinal Cord Independence Measure

  3. Spasticity

    Time frame: 6 months

    Spinal Cord Assessment Tool for Spastic Reflexes

  4. Health related quality of life

    Time frame: 6 months

    Short-form 36 and World Health Organization Quality of Life - BREF

Sponsors and collaborators

Lead sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Other

Collaborators

  • The Craig H. Neilsen Foundation
  • University of Louisville
  • Université de Montréal
  • École de technologie supérieure

Registry information

Official study title

Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury (PROMPT-SCI)

Acronym: PROMPT-SCI

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Jan 7, 2021
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.